Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-02-14 2:31 pm Sale | 13G | enVVeno Medical Corporation NVNO | PERCEPTIVE ADVISORS LLC | 937,515 9.9% | -16,733 (-1.75%) | View |
| 2022-02-14 4:38 pm Unchanged | 13G | enVVeno Medical Corporation NVNO | PERCEPTIVE ADVISORS LLC | 954,248 9.9% | 0 (Unchanged) | View |
| 2022-02-14 3:28 pm Sale | 13G | enVVeno Medical Corporation NVNO | CVI Investments Inc. | 280,357 2.9% | -155,357 (-35.66%) | View |
| 2022-02-11 07:39 am Purchase | 13G | enVVeno Medical Corporation NVNO | INTRACOASTAL CAPITAL LLC | 431,213 4.4% | 239,782 (+125.26%) | View |
| 2022-01-19 11:03 am Sale | 13G | enVVeno Medical Corporation NVNO | Empery Asset Management LP | 471,579 4.74% | -99,849 (-17.47%) | View |
| 2021-09-17 5:08 pm Purchase | 13G | Hancock Jaffe Laboratories Inc. HJLI | PERCEPTIVE ADVISORS LLC | 954,248 9.9% | 954,248 (New Position) | View |
| 2021-02-19 11:44 am Purchase | 13G | Hancock Jaffe Laboratories Inc. HJLI | CVI Investments Inc. | 435,714 5.6% | 435,714 (New Position) | View |
| 2021-02-17 10:12 am Purchase | 13G | Hancock Jaffe Laboratories Inc. HJLI | Empery Asset Management LP | 571,428 7.39% | 385,560 (+207.44%) | View |
| 2021-01-29 06:07 am Sale | 13G | Hancock Jaffe Laboratories Inc. HJLI | INTRACOASTAL CAPITAL LLC | 191,431 7% | -3,853,995 (-95.27%) | View |
| 2021-01-20 11:08 am Sale | 13G | Hancock Jaffe Laboratories Inc. HJLI | Empery Asset Management LP | 185,868 4.99% | -4,460,744 (-96.00%) | View |
| 2020-12-18 5:10 pm Sale | 13D | Hancock Jaffe Laboratories Inc. HJLI | FatBoy Capital L.P. | 26,250 1.2% | -130,000 (-83.20%) | View |
| 2020-12-16 12:05 pm Purchase | 13D | Hancock Jaffe Laboratories Inc. HJLI | FatBoy Capital L.P. | 156,250 6.9% | 156,250 (New Position) | View |
| 2020-10-15 10:53 am Purchase | 13G | Hancock Jaffe Laboratories Inc. HJLI | Empery Asset Management LP | 4,646,612 6.2% | 4,646,612 (New Position) | View |
| 2020-07-30 6:53 pm Purchase | 13G | Hancock Jaffe Laboratories Inc. HJLI | INTRACOASTAL CAPITAL LLC | 4,045,426 9.99% | 2,787,589 (+221.62%) | View |
| 2020-06-11 4:51 pm Purchase | 13G | Hancock Jaffe Laboratories Inc. HJLI | INTRACOASTAL CAPITAL LLC | 1,257,837 4.99% | 1,257,837 (New Position) | View |
| 2019-02-14 5:15 pm Purchase | 13G | Hancock Jaffe Laboratories Inc. HJLI | Zhivilo Yury | 4,478,581 38.2% | 4,478,581 (New Position) | View |
| 2018-12-26 06:11 am Sale | 13G | Hancock Jaffe Laboratories Inc. HJLI | ACT CAPITAL MANAGEMENT LLC | 503,500 4.3% | -256,500 (-33.75%) | View |
| 2018-08-10 7:41 pm Purchase | 13G | Hancock Jaffe Laboratories Inc. HJLI | Cantor Steven A. | 750,400 7.1% | 750,400 (New Position) | View |
| 2018-06-15 12:31 pm Purchase | 13G | Hancock Jaffe Laboratories Inc. HJLI | ACT CAPITAL MANAGEMENT LLC | 760,000 6.4% | 760,000 (New Position) | View |